Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF-Reference-Cited by-同舟云学术

Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF

Published:2020-09-30 Issue:11 Volume:22 Page:2093-2101
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Selvaraj Senthil¹,Claggett Brian L.²,Pfeffer Marc A.²,Desai Akshay S.²,Mc Causland Finnian R.³,McGrath Martina M.³,Anand Inder S.⁴,Veldhuisen Dirk J.⁵,Kober Lars⁶,Janssens Stefan⁷,Cleland John G.F.⁸,Pieske Burkert⁹,Rouleau Jean L.¹⁰,Zile Michael R.¹¹,Shi Victor C.¹²,Lefkowitz Martin P.¹²,McMurray John J.V.¹³,Solomon Scott D.²

Affiliation:

1. Division of Cardiology, Department of Medicine Hospital of the University of Pennsylvania Philadelphia PA USA

2. Division of Cardiology, Department of Medicine Brigham and Women's Hospital Boston MA USA

3. Renal Division Brigham and Women's Hospital, Harvard Medical School Boston MA USA

4. Department of Cardiovascular Medicine University of Minnesota Minneapolis MN USA

5. Department of Cardiology University of Groningen, University Medical Centre Groningen Groningen the Netherlands

6. Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

7. Department of Cardiology University Hospitals Leuven Belgium

8. Robertson Institute of Biostatistics and Clinical Trials Unit University of Glasgow Glasgow UK

9. Department of Internal Medicine and Cardiology German Centre for Cardiovascular Research partner site Berlin Berlin Germany

10. Montreal Institute of Cardiology University of Montreal Montreal QC Canada

11. Medical University of South Carolina and RHJ Department of Veterans Administration Medical Center Charleston SC USA

12. Novartis East Hanover NJ USA

13. British Heart Foundation Cardiovascular Research Centre University of Glasgow Glasgow UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1984

Reference31 articles.

1. Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction

2. Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure

3. Impact of Oxypurinol in Patients With Symptomatic Heart Failure

4. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients

5. Uric Acid and Survival in Chronic Heart Failure

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between serum uric acid levels and uric acid lowering therapy with the prognosis of patients with heart failure with preserved ejection fraction: a meta-analysis;Frontiers in Cardiovascular Medicine;2024-06-13

2. Serum Uric Acid, Hypertriglyceridemia, and Carotid Plaques: A Sub-Analysis of the URic Acid Right for Heart Health (URRAH) Study;Metabolites;2024-06-07

3. Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF;European Journal of Heart Failure;2024-04-08

4. HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients;Scientific Reports;2024-03-05

5. Comment on Li et al. Association of Serum Uric Acid With All-Cause and Cardiovascular Mortality in Diabetes. Diabetes Care 2023;46:425–433;Diabetes Care;2024-02-23